专题发言: VTE抗凝治疗进展的解读

2018-10-20 09:10-09:18

Conference Room 201-AB（2F）

Venous disease---Bayer Healthcare Co. Ltd.

Host

2018-10-20 09:10-10:50

Conference Room 201-AB（2F）

Venous disease---Bayer Healthcare Co. Ltd.

Host

2018-10-20 10:50-12:20

Conference Room 201-AB（2F）

Aortic arterial disease